High prices and cutbacks in ACA and Medicaid coverage leave many patients unable to medical bills.
|Slideshows|November 6, 2019
Eight Causes of Drug Shortages That are Burdening Healthcare
Author(s)MHE Staff
Drug shortages are a major problem and can have a negative impact on patient care and public health. Here, Dan Kistner, PharmD, senior vice president, pharmacy solutions for Vizient, talks about the top 8 reasons that drug shortages can occur.
Advertisement
Advertisement
Related to this article
In this discussion, Heather Burrell-Ward, M.D., provides an overview of her recent study that found TMS aimed at the default mode network improved processing speed in schizophrenia.
Rand researchers identify standardizing supplemental benefits, limiting the number of plans an insurer can market and reforming broker commissions as policy proposals that would benefit beneficiaries while not harming the government or the plans.
Reimagine Care and Dan Nardi scale CAR-T programs with remote cancer care, AI triage and nurses, as the Cureety partnership tackles staffing and access.
Biosimilars can cost $600 a month versus $6,000 for branded rivals, but PBM rebate incentives push formularies toward pricier drugs, says Christine Johnston.
Dan Nardi shares how Reimagine Care uses AI triage and connected devices to scale outpatient cancer support, enabling faster, personalized symptom monitoring.
In this interview, Jordan Herring, Ph.D., and Carlos E. Rodriguez-Diaz, Ph.D., MPHE, MCHES, discuss their study, which found a 16.8% increase in HIV incidence rates among Hispanic populations in antisanctuary counties after 2018 immigration policy shifts.
Metabolic dysfunction-associated steatotic liver disease (MASLD) may differ biologically from obesity-linked MASH, a mouse study suggests, with salt driving liver inflammation without obesity.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Christine Johnston on why biosimilars are losing formulary ground
2
Medicare Advantage needs fixing. Here are 3 feasible repairs
3
A conversation with Heather Burrell Ward, M.D., about developing TMS as a treatment for the cognitive symptoms of schizophrenia
4
Dan Nardi of Reimagine Care discusses how to help community practices scale CAR-T programs
5